Does MITOMYCIN Cause Second primary malignancy? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Second primary malignancy have been filed in association with MITOMYCIN (MUTAMYCIN). This represents 0.5% of all adverse event reports for MITOMYCIN.
10
Reports of Second primary malignancy with MITOMYCIN
0.5%
of all MITOMYCIN reports
8
Deaths
0
Hospitalizations
How Dangerous Is Second primary malignancy From MITOMYCIN?
Of the 10 reports, 8 (80.0%) resulted in death.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MITOMYCIN. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does MITOMYCIN Cause?
Off label use (292)
Drug ineffective (117)
Diarrhoea (116)
Nausea (100)
Neutropenia (96)
Thrombocytopenia (94)
Fatigue (88)
Disease progression (86)
Rash (67)
Vomiting (66)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which MITOMYCIN Alternatives Have Lower Second primary malignancy Risk?
MITOMYCIN vs MITOTANE
MITOMYCIN vs MITOXANTRONE
MITOMYCIN vs MITRAGYNINE\HERBALS
MITOMYCIN vs MIZORIBINE
MITOMYCIN vs MOBOCERTINIB